Skip to main content
    L

    Ligand Pharmaceuticals Incorporated (LGND)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $293.81
    -7.90 (-2.62%)

    Market Cap: $6.04B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Ligand Pharmaceuticals Incorporated (LGND) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Ligand Pharmaceuticals (LGND) has a latest price of $293.81 on Nov 17, 2026, 10.0% below its 52-week high of $326.63. Its price rose 46.3% over the past 12 months. The month-end price rose 237.1% over the 10 years through Oct 2026, a compound annual rate of 12.9%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $322.75 in Oct 2026 and its lowest $52.29 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart LGND with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LGND.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 1.1%, and over 6 months it rose 41.4%. The month-end price rose 517.2% over the 3 years through Oct 2026, a compound annual rate of 83.4%.

    PeriodChange
    1 month-1.2%
    3 months+1.1%
    6 months+41.4%
    12 months+46.3%
    12 months, with dividends+46.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+517.2%+83.4%
    5 years+121.2%+17.2%
    10 years+237.1%+12.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 76.5%, and its weakest was 2022, when it fell 56.8%.

    YearCloseChange
    2026 through Oct 2026$322.75+70.7%
    2025$189.07+76.5%
    2024$107.15+50.0%
    2023$71.42+6.9%
    2022$66.80-56.8%
    2021$154.46+55.3%
    2020$99.45-4.6%
    2019$104.29-23.1%
    2018$135.70-0.9%
    2017$136.93+34.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.8% below its 50-day average of $302.13 and 13.3% above its 200-day average of $259.40.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$293.81
    52-week high$326.63-10.0%
    52-week low$175.89+67.0%
    50-day average$302.13-2.8%
    200-day average$259.40+13.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 25.6%.

    MeasureValue
    1-year beta0.94
    Largest fall, 1 year-14.7%
    Largest fall, 3 years-25.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Ligand Pharmaceuticals traded at 27.9x earnings at the end of 2025, against a 5-year median of 17.9x and a 10-year median of 23.8x.

    LGND valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About LGND

    What is LGND's 1-year price change?

    Ligand Pharmaceuticals's price rose 46.3% over the past 12 months. With dividends included, the 12-month total return was 46.3%.

    What is LGND's 5-year price change?

    Ligand Pharmaceuticals's month-end price rose 121.2% over the 5 years through Oct 2026, a compound annual rate of 17.2%. These figures leave out dividends.

    What is LGND's 52-week high and low?

    Ligand Pharmaceuticals's 52-week high is $326.63 and its 52-week low is $175.89. Its latest price of $293.81 on Nov 17, 2026 is 10.0% below the high.

    What is LGND's beta?

    Ligand Pharmaceuticals's 1-year beta against the S&P 500 is 0.94, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 14.7%.

    Is the LGND chart free?

    Yes. Advanced Charting for LGND is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.